Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

19.38
-1.4800-7.09%
Post-market: 19.10-0.2800-1.44%19:59 EDT
Volume:22.37M
Turnover:439.36M
Market Cap:4.41B
PE:37.83
High:20.60
Open:20.58
Low:19.18
Close:20.86
52wk High:70.43
52wk Low:13.74
Shares:227.65M
Float Shares:197.51M
Volume Ratio:0.88
T/O Rate:11.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5123
EPS(LYR):0.5123
ROE:25.23%
ROA:5.29%
PB:8.16
PE(LYR):37.83

Loading ...

Hims & Hers Health Inc : Leerink Partners Raises Target Price to $25 From $17.5

THOMSON REUTERS
·
Mar 16

OWL, HIMS, TSLA And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week

Benzinga
·
Mar 14

Hims, Novo, CrowdStrike, SolarEdge, Telus Trending With Analysts

TIPRANKS
·
Mar 14

Surges 64% in Three Days. Hims & Hers Partners With Novo Nordisk, GLP-1 Weight-Loss Drug Channel War Begins in Earnest

TradingKey
·
Mar 12

Hims & Hers (HIMS) Stock Rallies 58% in Five Days — Can the Momentum Last?

TIPRANKS
·
Mar 12

Hims & Hers Health Shares up 5.1% Premarket Following Nearly 65% Surge in Past Three Sessions

THOMSON REUTERS
·
Mar 12

Premarket Movers | Hims & Hers Jumps 6%; Indonesia Energy, US Energy up 5%; XPeng, NIO up 3%; UiPath Falls 5%

Tiger Newspress
·
Mar 12

Stock Track | Hims & Hers Health Soars 5.33% in Pre-market on Strategic Overhaul and Novo Nordisk Collaboration

Stock Track
·
Mar 12

Stock Track | Hims & Hers Health Soars 5.02% on Strategic Overhaul and Novo Nordisk Collaboration

Stock Track
·
Mar 12

Hims & Hers revamps GLP-1 strategy with Novo Nordisk

TIPRANKS
·
Mar 12

Hims & Hers Plans to Expand Access to FDA-Approved GLP-1 Weight Loss Drugs via Novo Nordisk Collaboration, Limit Compounded Semaglutide and Transition Eligible Patients

Reuters
·
Mar 12

Hims & Hers rises 14.5%

TIPRANKS
·
Mar 12

Hims & Hers Health Stock Is Surging Wednesday: What's Going On?

Benzinga
·
Mar 11

Hims & Hers Health Is Maintained at Overweight by Barclays

Dow Jones
·
Mar 11

Hims & Hers Stock Soars 14% After It Hires Former Lilly Communications Chief

Tiger Newspress
·
Mar 11

Stock Track | Hims & Hers Health Soars 5.16% Intraday on Barclays Price Target Hike and Novo Nordisk Weight-Loss Drug Deal

Stock Track
·
Mar 11

Hims & Hers Health : Barclays Raises Target Price to $29 From $25

THOMSON REUTERS
·
Mar 11

HIMS-Novo ‘Can’t Quit Each Other’ – Bulls Rally on Wegovy Deal

TIPRANKS
·
Mar 11

U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, Oracle

Reuters
·
Mar 11

Hims & Hers Appoints Eli Lilly Communications Veteran to Lead Branded Weight-Loss Drug Push

Stock News
·
Mar 11